Anti-RPL35 monoclonal antibody

Pre-made anti-RPL35 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RPL35/RPL35 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1546-Ab-1/ GM-Tg-hg-IP1546-Ab-2Anti-Human RPL35 monoclonal antibodyHuman
GM-Tg-rg-IP1546-Ab-1/ GM-Tg-rg-IP1546-Ab-2Anti-Rat RPL35 monoclonal antibodyRat
GM-Tg-mg-IP1546-Ab-1/ GM-Tg-mg-IP1546-Ab-2Anti-Mouse RPL35 monoclonal antibodyMouse
GM-Tg-cynog-IP1546-Ab-1/ GM-Tg-cynog-IP1546-Ab-2Anti-Cynomolgus/ Rhesus macaque RPL35 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1546-Ab-1/ GM-Tg-felg-IP1546-Ab-2Anti-Feline RPL35 monoclonal antibodyFeline
GM-Tg-cang-IP1546-Ab-1/ GM-Tg-cang-IP1546-Ab-2Anti-Canine RPL35 monoclonal antibodyCanine
GM-Tg-bovg-IP1546-Ab-1/ GM-Tg-bovg-IP1546-Ab-2Anti-Bovine RPL35 monoclonal antibodyBovine
GM-Tg-equg-IP1546-Ab-1/ GM-Tg-equg-IP1546-Ab-2Anti-Equine RPL35 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1546-Ab-1/ GM-Tg-hg-IP1546-Ab-2; GM-Tg-rg-IP1546-Ab-1/ GM-Tg-rg-IP1546-Ab-2;
GM-Tg-mg-IP1546-Ab-1/ GM-Tg-mg-IP1546-Ab-2; GM-Tg-cynog-IP1546-Ab-1/ GM-Tg-cynog-IP1546-Ab-2;
GM-Tg-felg-IP1546-Ab-1/ GM-Tg-felg-IP1546-Ab-2; GM-Tg-cang-IP1546-Ab-1/ GM-Tg-cang-IP1546-Ab-2;
GM-Tg-bovg-IP1546-Ab-1/ GM-Tg-bovg-IP1546-Ab-2; GM-Tg-equg-IP1546-Ab-1/ GM-Tg-equg-IP1546-Ab-2
Products NameAnti-RPL35 monoclonal antibody
Formatmab
Target NameRPL35
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RPL35 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1546-Ag-1Recombinant multi-species RL35/ RPL35/ L35 protein
    ORF Viral VectorpGMAP000518Human RPL35 Adenovirus plasmid
    ORF Viral VectorvGMAP000518Human RPL35 Adenovirus particle


    Target information

    Target IDGM-IP1546
    Target NameRPL35
    Gene ID11224,66489,296709,693604,480729,101081766,515534,100070944
    Gene Symbol and Synonyms2410039E09Rik,DBA19,L35,RPL35,uL29
    Uniprot AccessionP42766,P17078,Q3MHM7
    Uniprot Entry NameRL35_HUMAN,RL35_RAT,RL35_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000136942
    Target ClassificationN/A

    The target: RPL35, gene name: RPL35, also named as L35. Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L29P family of ribosomal proteins. It is located in the cytoplasm. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.